Disclosed is an ophthalmic composition comprising an effective amount of a therapeutically active agent, stabilized chlorine dioxide, and citric acid and/or conjugate bases thereof. An example of the stabilised chlorine dioxide is Purite. Also disclosed is a method of stabilising incompatible components of a composition.